COVID-19 bites into Pfizer’s Q3, but biopharma revenues risePfizer is one of the front-runners in the race to approve a COVID-19 vaccine but the US company Share XCOVID-19 bites into Pfizer’s Q3, but biopharma revenues risehttps://pharmaphorum.com/news/covid-bites-into-pfizers-q3-but-biopharma-revenues-rise/
COVID-19 ventilator demand fuels Philips Q3 salesHuge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Share XCOVID-19 ventilator demand fuels Philips Q3 saleshttps://pharmaphorum.com/news/covid-19-ventilator-demand-fuels-philips-q3-sales/
